Relay Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:RLAY) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -73.21 M-55.26 M-62.12 M-44.87 M-51.11 M -213.36 M Cash from investing activities 42.47 M75.15 M39.73 M35.46 M32.9 M 183.24 M Cash from financing activities 48.92 M1.54 M17 K934 K138.78 M — Free cash flow -73.21 M-55.26 M-62.12 M-44.87 M-51.11 M -213.36 M

News

Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026 (CELC)

Biotech Is The Rate Cut Trade In Disguise

Absci: Eli Lilly Backs Alopecia Data With Funding, But Risks Remain (NASDAQ:ABSI)

The Prognosis For Palvella Therapeutics (NASDAQ:PVLA)

Two Months. $10 Million. A Sputnik Moment for AI.

Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise (NASDAQ:RLAY)

Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies Transcript

Rising Bond Yields Weigh on Stocks

Stocks Pressured by Tech Weakness and Rising Bond Yields

This Biotech's Drug Just Wiped The Floor With Forecasts

Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates

Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates